Literature DB >> 26115192

Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System.

Christian Wüthrich1, Stephanie Batson, Igor J Koralnik.   

Abstract

The human polyomavirus JC (JCV) infects glial cells in immunosuppressed individuals, leading to progressive multifocal leukoencephalopathy. Polyomavirus JC can also infect neurons in patients with JCV granule cell neuronopathy and JCV encephalopathy. CD8-positive T cells play a crucial role in viral containment and outcome in progressive multifocal leukoencephalopathy, but whether CD8-positive T cells can also recognize JCV-infected neurons is unclear. We used immunohistochemistry to determine the prevalence of T cells in neuron-rich areas of archival brain samples from 77 patients with JCV CNS infections and 94 control subjects. Neurons predominantly sustained a restrictive infection with expression of JCV regulatory protein T antigen (T Ag), whereas glial cells were productively infected and expressed both T Ag and the capsid protein VP1. T cells were more prevalent near JCV-infected cells with intact nuclei expressing both T Ag and VP1 compared with those expressing either protein alone. CD8-positive T cells also colocalized more with JCV-infected glial cells than with JCV-infected neurons. Major histocompatibility complex class I expression was upregulated in JCV-infected areas but could only be detected in rare neurons interspersed with infected glial cells. These results suggest that isolated neurons harboring restrictive JCV infection do not upregulate major histocompatibility complex class I and thus may escape recognition by CD8-positive T cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26115192      PMCID: PMC4506730          DOI: 10.1097/NEN.0000000000000218

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  58 in total

1.  Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.

Authors:  Gert Van Assche; Marc Van Ranst; Raf Sciot; Bénédicte Dubois; Séverine Vermeire; Maja Noman; Jannick Verbeeck; Karel Geboes; Wim Robberecht; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

2.  Viral persistence in neurons explained by lack of major histocompatibility class I expression.

Authors:  E Joly; L Mucke; M B Oldstone
Journal:  Science       Date:  1991-09-13       Impact factor: 47.728

3.  JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

Authors:  I J Koralnik; R A Du Pasquier; N L Letvin
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Expression of major histocompatibility complex antigens in the brains of patients with progressive multifocal leukoencephalopathy.

Authors:  C L Achim; C A Wiley
Journal:  J Neuropathol Exp Neurol       Date:  1992-05       Impact factor: 3.685

5.  Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy.

Authors:  Christian Wüthrich; Igor J Koralnik
Journal:  J Neuropathol Exp Neurol       Date:  2012-01       Impact factor: 3.685

6.  A fatal case of JC virus meningitis presenting with hydrocephalus in a human immunodeficiency virus-seronegative patient.

Authors:  Shruti P Agnihotri; Christian Wuthrich; Xin Dang; David Nauen; Reza Karimi; Raphael Viscidi; Evelyn Bord; Stephanie Batson; Juan Troncoso; Igor J Koralnik
Journal:  Ann Neurol       Date:  2014-06-20       Impact factor: 10.422

7.  Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection.

Authors:  Grégoire Chevalier; Elsa Suberbielle; Céline Monnet; Valérie Duplan; Guillaume Martin-Blondel; Fanny Farrugia; Gwendal Le Masson; Roland Liblau; Daniel Gonzalez-Dunia
Journal:  PLoS Pathog       Date:  2011-11-17       Impact factor: 6.823

8.  JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant.

Authors:  Xin Dang; Christian Wüthrich; Jennifer Gordon; Hirofumi Sawa; Igor J Koralnik
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

9.  PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.

Authors:  J Killestein; A Vennegoor; A E L van Golde; R L J H Bourez; M L B Wijlens; M P Wattjes
Journal:  Case Rep Neurol Med       Date:  2014-11-23

10.  Agnogene deletion in a novel pathogenic JC virus isolate impairs VP1 expression and virion production.

Authors:  Laura C Ellis; Elizabeth Norton; Xin Dang; Igor J Koralnik
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more
  5 in total

Review 1.  The neurobiological basis of narcolepsy.

Authors:  Carrie E Mahoney; Andrew Cogswell; Igor J Koralnik; Thomas E Scammell
Journal:  Nat Rev Neurosci       Date:  2019-02       Impact factor: 34.870

Review 2.  Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.

Authors:  Niraj Kumar Jha; Shreesh Ojha; Saurabh Kumar Jha; Harish Dureja; Sachin Kumar Singh; Shakti D Shukla; Dinesh Kumar Chellappan; Gaurav Gupta; Shanu Bhardwaj; Neeraj Kumar; Madhan Jeyaraman; Rashmi Jain; Sathish Muthu; Rohan Kar; Dhruv Kumar; Vineet Kumar Goswami; Janne Ruokolainen; Kavindra Kumar Kesari; Sandeep Kumar Singh; Kamal Dua
Journal:  J Mol Neurosci       Date:  2021-01-19       Impact factor: 2.866

Review 3.  A review of pathophysiology and neuropsychiatric manifestations of COVID-19.

Authors:  Madhu Jasti; Krishna Nalleballe; Vasuki Dandu; Sanjeeva Onteddu
Journal:  J Neurol       Date:  2020-06-03       Impact factor: 6.682

Review 4.  Nervous system involvement after infection with COVID-19 and other coronaviruses.

Authors:  Yeshun Wu; Xiaolin Xu; Zijun Chen; Jiahao Duan; Kenji Hashimoto; Ling Yang; Cunming Liu; Chun Yang
Journal:  Brain Behav Immun       Date:  2020-03-30       Impact factor: 7.217

Review 5.  Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease.

Authors:  Irene Cortese; Daniel S Reich; Avindra Nath
Journal:  Nat Rev Neurol       Date:  2020-11-20       Impact factor: 42.937

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.